Thomas C, Ged C, Nordmann Y, de Verneuil H, Pellier I, Fischer A, Blanche S
Unité d'Immuno-Hématologie, Hôpital Necker, Paris, France.
J Pediatr. 1996 Sep;129(3):453-6. doi: 10.1016/s0022-3476(96)70082-3.
Congenital erythropoietic porphyria (Gunther disease) is a rare metabolic disorder caused by uroporphyrinogen III synthetase deficiency. We report the case of a 2-year-old girl with a severe form of this disease who received HLA-identical bone marrow transplantation from her heterozygous sister. Two transplantations were necessary to obtain full hematopoietic chimerism. Correction of the enzyme deficiency was confirmed by measuring erythrocyte uroporphyrinogen III synthetase activity. The patient's clinical condition improved dramatically, and she is well 1 year after the second transplantation, with no further treatment. Although long-term efficacy remains to be confirmed, we conclude that allogeneic bone marrow transplantation can cure patients with congenital erythropoietic porphyria.
先天性红细胞生成性卟啉病(贡瑟病)是一种由尿卟啉原III合成酶缺乏引起的罕见代谢紊乱疾病。我们报告了一名患有严重形式该疾病的2岁女孩的病例,她接受了来自其杂合子姐姐的人类白细胞抗原(HLA)匹配的骨髓移植。需要进行两次移植才能实现完全造血嵌合。通过测量红细胞尿卟啉原III合成酶活性证实了酶缺乏得到纠正。患者的临床状况显著改善,第二次移植后1年情况良好,无需进一步治疗。尽管长期疗效仍有待证实,但我们得出结论,同种异体骨髓移植可以治愈先天性红细胞生成性卟啉病患者。